This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
Gary Sergott felt weary all the time. “I’d get tired, short of breath, a sort of malaise,” he said. He was cold even on warm days and looked pale with dark circles under his eyes. His malady was not mysterious. As a retired nurse anesthetist, Sergott knew he had anemia, a deficiency of red blood…
The PTC Therapeutics gene therapy, Kebilidi, treats an enzyme deficiency that affects the body’s ability to produce dopamine, a neurotransmitter important for motor control. FDA approval for the product comes two years after it won its first regulatory approvals in Europe. The post PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly…
In collaboration with Google Cloud, Suki added two capabilities to its AI assistant: patient summaries and Q&A functionality. These new features might help Suki differentiate itself from other companies selling AI-powered tools to help with documentation and coding, such as Abridge, DeepScribe and Microsoft. The post Suki Adds New Features to Help Its AI Assistant…
CMS’s Office of the Actuary predicts that national healthcare expenditures (NHE) will increase from 17.6% of GDP in 2023 to 20.3% of GDP by 2033. The Keehan et al. (2025) paper provides more details: National health expenditures are projected to have grown 8.2 percent in 2024 and to increase 7.1 percent in 2025, reflecting continued…
That is the title of my paper out today in the Journal of Comparative Effectiveness Research written with co-authors Adam Kittai, Dipen Patel, Nadine Zawadzki, Vikram Shetty, Yazan Barqawi, and Joanna Rhodes. The abstract is below. Aim: To estimate cost savings associated with covalent Bruton’s tyrosine kinase inhibitor (cBTKi) choice in patients with treatment-naive (TN) and…
ISPOR recently released their award winners from their 2025 conference this May. Winners are listed below. I’m excited to announce that my podium presentation “Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection” received an award for the Best General Podium…
In response to emailed questions, the founders of MucoLife Therapeutics shared their company’s approach, which is designed to help people with COPD, cystic fibrosis, asthma, and pulmonary fibrosis. The post A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care appeared first on MedCity News.
Considerations for Developing Hospital Cleaning Procedures and Methods Elements of the Process The cleaning process depends on the people, protocols, and products involved. With various surfaces, equipment, and intricate designs, the hospital setting presents a unique challenge. In addition to creating efficient protocols and using effective products to clean and disinfect, hospitals must empower associates to…